Medicure (OTCMKTS:MCUJF – Get Free Report) is anticipated to release its results after the market closes on Wednesday, August 19th. Analysts expect the company to announce earnings of ($0.0474) per share and revenue of $2.4460 million for the quarter.
Medicure (OTCMKTS:MCUJF – Get Free Report) last announced its quarterly earnings data on Thursday, May 21st. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.01. Medicure had a negative net margin of 21.65% and a negative return on equity of 44.34%. The firm had revenue of $5.79 million during the quarter, compared to analyst estimates of $3.63 million.
Medicure Stock Performance
MCUJF opened at $0.85 on Wednesday. The stock has a market capitalization of $8.87 million, a PE ratio of -1.81 and a beta of 0.99. Medicure has a one year low of $0.67 and a one year high of $0.97. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 1.04. The business’s 50 day moving average price is $0.76 and its 200 day moving average price is $0.81.
About Medicure
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Featured Stories
- Five stocks we like better than Medicure
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
